Sponsor Pipeline

Joshua Brody Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
4
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-05 NCT07748364 Glofitamab in B-NHL Using Mid-Therapy Intratumoral Transcriptomics Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07748364 Glofitamab in B-NHL Using Mid-Therapy Intratumoral Transcriptomics Relapsed/Refractory Diffuse Large B-cell Lymphoma Not Yet Recruiting
Phase 1/2
NCT03153202 Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in… Chronic Lymphocytic Leukemia Active, Not Recruiting
Disease Areas
Mantle Cell Lymphoma (2) Leukemia (1) Chronic Lymphocytic Leukemia (CLL) (1) DLBCL (1)
Get alerts when Joshua Brody's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free